NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

thank you for answering

I understand that is educational.
If the article would come anytime soon, then why is this article needed? Is Northwest still in the explanation phase of external control as we have seen for months with Dr Liau? If the FDA accepted, bought in the new endpoints then why is this article needed?

Answer positive
To not have to explain the need for external control in the DCVA article, this saves space in the DCVAX trial outcome article we will see soon.
To avoid attacks from shorters external-patients with DCVAX vs placebo-control

Answer negative
They still need to convince RA and scientists to accept external control vs trial.. and so it will take longer again

I hope its the first ofcourse